Unified Neural Architecture for Drug, Disease and Clinical Entity Recognition

Most existing methods for biomedical entity recognition task rely on explicit feature engineering where many features either are specific to a particular task or depends on output of other existing NLP tools. Neural architectures have been shown across various domains that efforts for explicit feature design can be reduced... (read more)

Results in Papers With Code
(↓ scroll down to see all results)